Tamoxifen can: reduce the risk of breast cancer coming back by 40% to 50% in postmenopausal women and by 30% to 50% in premenopausal women. reduce the risk of a new cancer developing in the other breast by about 50% shrink large, hormone-receptor-positive breast cancers before surgery.
Even with all that fanfare, tamoxifen has been loosely associated with weight gain. Studies have tracked weight gain and other side effects of the drug for years. Some resources even list weight gain as a possible side effect.
Some breast cancer treatments have been associated with increased stroke risk: Tamoxifen: Some studies have found that there is a small but real increase in stroke risk in women who take tamoxifen, probably due to the increased risk of blood clot formation.
The results suggest that tamoxifen treatment causes significant reduction in breast density, and that the reduction is positively correlated with the baseline density and the treatment duration.
Tamoxifen significantly decreased the rate of skeletal maturation and increased the predicted adult height without negative effects on sexual maturation.
Bodybuilders have been using tamoxifen for more than 30 years to treat gynecomastia, a side effect of taking too much testosterone. Excess estrogen is produced as a byproduct of having too much testosterone.
be taken with food or on an empty stomach with a glass of water or juice. Tamoxifen may be taken at any time of the day but should be taken at the same time each day. it is within 12 hours of the missed dose.
Elevated estrogen not only diminishes men's testosterone levels. It can also put both men and women at risk for heart disease and certain types of cancer. According to the Journal of Medicinal Food, estrogen-blocking foods that contain phytochemicals can help reduce estrogen levels in the bloodstream.
A new study shows that a drug similar to one used to help women ovulate can raise testosterone levels and sperm counts in men. The drug, called enclomiphene citrate, may prove to be more effective in treating men with low testosterone than the testosterone gels and injections currently prescribed.
In such cases, treating the underlying condition or stopping the drug usually allows gynecomastia to resolve. When the cause of gynecomastia cannot be identified, brief use of tamoxifen may be recommended. Men who have had gynecomastia for more than one year do not typically benefit from the use of tamoxifen.
Estrogen, the female sexual hormone, also affects erectile function, as demonstrated in both clinical and basic studies. Interestingly, estradiol-testosterone imbalance is considered a risk factor for ED. Furthermore, endocrine-disrupting chemicals have estrogen-like effects and cause ED.
Clomid is typically used as an infertility treatment in females. It's not approved by the FDA for use in males, but it's often prescribed off-label for treatment of male infertility. Taking Clomid can lead to an increase in testosterone and sperm count. Studies on its efficacy in males have had mixed results.
While long-term tamoxifen use among breast cancer survivors decreases their risk of developing the most common, less aggressive type of second breast cancer, such use is associated with a more than four-fold increased risk of a more aggressive, difficult-to-treat type of cancer in the breast opposite, or contralateral,
Some people go through mood swings or feel low or depressed while they are taking tamoxifen. Or it may be harder to think clearly or concentrate. Tell your doctor or nurse if this is a problem, especially if you are feeling depressed. Tamoxifen may slightly increase your chances of having a blood clot.
A new study has found that while the breast cancer prevention drug tamoxifen's benefits outweigh its risks, the drug isn't right for all women. A new study has found that while the breast cancer prevention drug tamoxifen's benefits outweigh its risks, the drug isn't right for all women.
Certain medications used to treat depression should be avoided by women taking tamoxifen. The antidepressants paroxetine (Paxil) and fluoxetine (Prozac) have been found to increase women's risk of dying of cancer if they are taking tamoxifen.
TUESDAY, Sept. 17 (HealthDay News) -- Some women who take tamoxifen to treat or prevent breast cancer report experiencing a mental fogginess while on the drug, and researchers have now confirmed that there's a biological basis for those symptoms.
endings in your skin, it can cause your skin to feel more sensitive to touch. The hormonal therapy tamoxifen, as well as targeted therapies such as lapatinib (Tykerb), neratinib (Nerlynx), and everolimus (Afinitor) can cause nail and skin changes as well.
One of the adverse effects of tamoxifen include hot flashes and vaginal dryness (reviewed in Neven and Vergotta 2001), but there have been no studies to determine effects on skin thickness, collagen content, elastic fibers or the formation of wrinkles.
We observed that green tea increased the inhibitory effect of tamoxifen on the proliferation of the ER (estrogen receptor)-positive MCF-7, ZR75, T47D human breast cancer cells in vitro . This combination regimen was also more potent than either agent alone at increasing cell apoptosis.
While tamoxifen acts like an anti-estrogen in breast cells, it acts like an estrogen in other tissues, like the uterus and the bones. Because of this, it is called a selective estrogen receptor modulator (SERM). It can be used to treat women with breast cancer who have or have not gone through menopause.
Although tamoxifen is effective, many women stop taking it before they finish the full treatment course. Some may stop because of common side effects, such as hot flashes, vaginal dryness and mood swings. Others may worry about tamoxifen's rare side effects, including blood clots and increased risk of uterine cancer.
Earlier ATAC results found that Arimidex was more effective than tamoxifen in reducing the risk of recurrence of early-stage, hormone-receptor-positive breast cancer in postmenopausal women. Other studies comparing tamoxifen to the other two aromatase inhibitors (Aromasin and Femara) have shown similar results.
One of the most common side effects mentioned was “brain fog” – memory loss and concentration issues brought on by use of tamoxifen or aromatase inhibitors.
Low-dose tamoxifen ocular toxicity is well documented and its incidence was reported to be 6.3 and 12% in two prospective studies. The common toxic effects included inner retinal crystalline deposition, macular oedema, whorl-like corneal opacities, posterior subcapsular lens opacities, optic neuritis and affected EOG.
If you experience side effects and decide to take a break from taking tamoxifen, it is likely that the side effects will reappear once you start taking the drug again. Menopausal-like symptoms are fairly common but are usually mild and disappear when tamoxifen is no longer taken.
A woman who has been diagnosed with any type of uterine cancer or atypical hyperplasia of the uterus (a kind of pre-cancer) should not take tamoxifen to help lower breast cancer risk. Raloxifene has not been tested in pre-menopausal women, so it should only be used if you have gone through menopause.
Breast cancer patients can stop tamoxifen after 5 yearsWomen who have had breast cancer gain no benefit from taking tamoxifen for longer than 5 years, a new study has found. Researchers randomly assigned 1,172 women who had already taken tamoxifen for 5 years to continue taking either the drug or a placebo.
A recent clinical trial found that women who were post-menopausal and who had taken tamoxifen, an aromatase inhibitor or both (one after the other) continuously for five years could safely take a three-month break from treatment each year for the next five years.
